|
GB1319315A
(en)
|
1969-06-19 |
1973-06-06 |
Citizen Watch Co Ltd |
Calendar timepiece
|
|
US3940475A
(en)
|
1970-06-11 |
1976-02-24 |
Biological Developments, Inc. |
Radioimmune method of assaying quantitatively for a hapten
|
|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
|
US3939350A
(en)
|
1974-04-29 |
1976-02-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Fluorescent immunoassay employing total reflection for activation
|
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4277437A
(en)
|
1978-04-05 |
1981-07-07 |
Syva Company |
Kit for carrying out chemically induced fluorescence immunoassay
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
|
US4957939A
(en)
|
1981-07-24 |
1990-09-18 |
Schering Aktiengesellschaft |
Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
|
|
US4472509A
(en)
|
1982-06-07 |
1984-09-18 |
Gansow Otto A |
Metal chelate conjugated monoclonal antibodies
|
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US6492107B1
(en)
|
1986-11-20 |
2002-12-10 |
Stuart Kauffman |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
|
CH0229046H1
(de)
|
1985-03-30 |
1998-07-15 |
Stuart Alan Kauffman |
Method for obtaining dna, rna, peptides, polypeptinique. des or proteins by means of a dna recombinant tech
|
|
US4737456A
(en)
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
|
US4938948A
(en)
|
1985-10-07 |
1990-07-03 |
Cetus Corporation |
Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
DE3600905A1
(de)
|
1986-01-15 |
1987-07-16 |
Ant Nachrichtentech |
Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
|
|
US5681718A
(en)
|
1986-03-14 |
1997-10-28 |
Celltech Limited |
Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
JP3040121B2
(ja)
|
1988-01-12 |
2000-05-08 |
ジェネンテク，インコーポレイテッド |
増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US20030229208A1
(en)
|
1988-12-28 |
2003-12-11 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
|
CA2016842A1
(en)
|
1989-05-16 |
1990-11-16 |
Richard A. Lerner |
Method for tapping the immunological repertoire
|
|
CA2016841C
(en)
|
1989-05-16 |
1999-09-21 |
William D. Huse |
A method for producing polymers having a preselected activity
|
|
CA2057923A1
(en)
|
1989-05-16 |
1990-11-17 |
William D. Huse |
Co-expression of heteromeric receptors
|
|
JPH049249A
(ja)
|
1990-04-27 |
1992-01-14 |
Kusuda:Kk |
塗型剤吹き付け機
|
|
US6916605B1
(en)
|
1990-07-10 |
2005-07-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
DE69127627T2
(de)
|
1990-08-29 |
1998-02-19 |
Genpharm Int |
Produktion und Nützung nicht-menschliche transgentiere zur Produktion heterologe Antikörper
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
ATE164395T1
(de)
|
1990-12-03 |
1998-04-15 |
Genentech Inc |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
ATE408012T1
(de)
|
1991-12-02 |
2008-09-15 |
Medical Res Council |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
ES2202310T3
(es)
|
1991-12-13 |
2004-04-01 |
Xoma Corporation |
Metodos y materiales para la preparacion de dominios variables de anticuerpos modificados y sus usos terapeuticos.
|
|
PT627940E
(pt)
|
1992-03-05 |
2003-07-31 |
Univ Texas |
Utilizacao de imunoconjugados para o diagnostico e/ou terapia de tumores vascularizados
|
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US20030148406A1
(en)
|
1992-03-17 |
2003-08-07 |
David John King |
Multivalent antigen-binding proteins
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
WO1994029351A2
(en)
|
1993-06-16 |
1994-12-22 |
Celltech Limited |
Antibodies
|
|
US5432930A
(en)
|
1993-09-30 |
1995-07-11 |
Eagle Crest Limited |
System for accessing cobol data files by generating a dictionary of NF.sup.2
|
|
NL9302194A
(nl)
|
1993-12-15 |
1995-07-03 |
Nidera Handelscompagnie B V |
Werkwijze voor het bereiden van een samengevoegd visprodukt, alsmede visprodukt verkregen onder toepassing van deze werkwijze.
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
DE19526926A1
(de)
|
1995-07-24 |
1997-01-30 |
Bayer Ag |
Verfahren zur Herstellung beladener nichtporöser Trägermaterialien
|
|
DK1143006T3
(da)
|
1995-08-18 |
2008-07-14 |
Morphosys Ip Gmbh |
Vektorer/DNA-sekvenser fra humane kombinatoriske antistofbiblioteker
|
|
US6696248B1
(en)
|
1995-08-18 |
2004-02-24 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
|
JP2002514895A
(ja)
|
1995-09-28 |
2002-05-21 |
アレクション、ファーマスーティカルズ、インコーポレーテッド |
ブタ細胞相互作用タンパク質
|
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
|
US6596850B1
(en)
|
1998-01-30 |
2003-07-22 |
Ixsys, Incorporated |
Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
|
|
CA2354862A1
(en)
|
1998-10-19 |
2000-04-27 |
Yeda Research And Development Co. Ltd. |
Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
|
|
US20040031072A1
(en)
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
|
ATE482275T1
(de)
|
1999-07-02 |
2010-10-15 |
Morphosys Ag |
Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden
|
|
IT1307309B1
(it)
|
1999-12-30 |
2001-10-30 |
Enea Ente Nuove Tec |
Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono.
|
|
EP1267918A4
(en)
|
2000-03-31 |
2007-06-27 |
Purdue Research Foundation |
METHOD OF TREATMENT USING LIGAND-IMMUNOGENE CONJUGATES
|
|
DE10037759A1
(de)
|
2000-08-03 |
2002-07-04 |
Gruenenthal Gmbh |
Screeningverfahren
|
|
ATE400030T1
(de)
|
2001-02-19 |
2008-07-15 |
Merck Patent Gmbh |
Methode zur identifizierung von t-zellepitopen und deren anwendung zur herstellung von molekülen mit reduzierter immunogenität
|
|
WO2002071928A2
(en)
|
2001-03-14 |
2002-09-19 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
|
EP1390077B1
(en)
|
2001-05-02 |
2014-07-16 |
Purdue Research Foundation |
Treatment and diagnosis of macrophage mediated disease
|
|
US7314974B2
(en)
|
2002-02-21 |
2008-01-01 |
Monsanto Technology, Llc |
Expression of microbial proteins in plants for production of plants with improved properties
|
|
WO2003074704A1
(fr)
|
2002-03-01 |
2003-09-12 |
Japan Envirochemicals, Ltd. |
Proteines capables de se lier aux hormones sexuelles feminines et procede de preparation
|
|
MY154009A
(en)
*
|
2002-03-13 |
2015-04-30 |
Biogen Idec Inc |
Anti-alpha v beta 6 antibodies
|
|
US7531522B2
(en)
|
2002-04-22 |
2009-05-12 |
Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. |
Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
|
|
GB0216648D0
(en)
|
2002-07-18 |
2002-08-28 |
Lonza Biologics Plc |
Method of expressing recombinant protein in CHO cells
|
|
DK2213685T3
(en)
*
|
2002-09-06 |
2014-03-03 |
Medarex Llc |
Therapeutic anti-IL-1R1 monoclonal antibody
|
|
AU2003295411A1
(en)
|
2002-11-07 |
2004-06-03 |
Celltech R & D |
Human monoclonal antibodies to heparanase
|
|
EP1481993A1
(en)
|
2003-05-28 |
2004-12-01 |
Xerion Pharmaceuticals AG |
Modulation of the poliovirus receptor function
|
|
US20080131366A1
(en)
|
2003-03-17 |
2008-06-05 |
Manohar Ratnam |
Folate Receptor Gene Modulation For Cancer Diagnosis And Therapy
|
|
US20050255114A1
(en)
|
2003-04-07 |
2005-11-17 |
Nuvelo, Inc. |
Methods and diagnosis for the treatment of preeclampsia
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
JP5416338B2
(ja)
|
2003-05-09 |
2014-02-12 |
デューク ユニバーシティ |
Ｃｄ２０特異的抗体およびその使用方法
|
|
CN1816356A
(zh)
|
2003-05-14 |
2006-08-09 |
免疫原公司 |
药物缀合物组合物
|
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
MXPA05014153A
(es)
|
2003-07-02 |
2006-07-03 |
Genentech Inc |
Composiciones y metodoso para el diagnostico y tratamiento de tumor.
|
|
WO2005054469A1
(en)
|
2003-12-05 |
2005-06-16 |
Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health |
Anti-sars monoclonal antibodies
|
|
AU2005214331B2
(en)
|
2004-02-12 |
2011-09-15 |
Eisai, Inc. |
Monoclonal antibodies that specifically bind to folate receptor alpha
|
|
WO2005075514A2
(en)
|
2004-03-10 |
2005-08-18 |
Lonza Ltd. |
Method for producing antibodies
|
|
CA2562833A1
(en)
|
2004-04-27 |
2005-11-03 |
Galapagos N.V. |
Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
|
|
CA2581208A1
(en)
|
2004-08-30 |
2006-03-09 |
Lonza Biologics Plc. |
Affinity- plus ion exchange- chromatography for purifying antibodies
|
|
US7776869B2
(en)
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
|
EP2465872A3
(en)
|
2004-10-25 |
2012-12-19 |
Merck Sharp & Dohme Corporation |
Anti-ADDL antibodies and uses thereof
|
|
US20070294782A1
(en)
|
2004-12-21 |
2007-12-20 |
Mark Abad |
Transgenic plants with enhanced agronomic traits
|
|
CA2592015A1
(en)
*
|
2004-12-27 |
2006-07-06 |
Progenics Pharmaceuticals (Nevada), Inc. |
Orally deliverable and anti-toxin antibodies and methods for making and using them
|
|
US20080181888A1
(en)
|
2004-12-31 |
2008-07-31 |
Ambrose Christine M |
Polypeptides That Bind Br3 and Uses Thereof
|
|
JP2008528060A
(ja)
|
2005-01-27 |
2008-07-31 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ボツリヌス神経毒素を中和する治療的モノクローナル抗体
|
|
US7608413B1
(en)
|
2005-03-25 |
2009-10-27 |
Celera Corporation |
Kidney disease targets and uses thereof
|
|
US7812135B2
(en)
|
2005-03-25 |
2010-10-12 |
Tolerrx, Inc. |
GITR-binding antibodies
|
|
AU2006230219A1
(en)
|
2005-03-30 |
2006-10-05 |
Endocyte, Inc. |
Method for cancer prognosis using cellular folate vitamin receptor quantification
|
|
US20060239910A1
(en)
|
2005-04-22 |
2006-10-26 |
Morphotek Inc. |
Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
|
|
WO2006121207A1
(en)
|
2005-05-12 |
2006-11-16 |
Oncotherapy Science, Inc. |
Methods for damaging cells using effector function of anti-dsc2 antibody
|
|
JP4991705B2
(ja)
|
2005-05-20 |
2012-08-01 |
ロンザ・バイオロジクス・ピーエルシー |
哺乳類宿主細胞における組換え抗体の高レベル発現
|
|
MX2007014673A
(es)
|
2005-05-24 |
2008-04-08 |
Avestha Gengraine Tech Pvt Ltd |
Metodo para la produccion de un anticuerpo monoclonal para cd20 para el tratamiento de linfoma de celular b.
|
|
EP1904183B1
(en)
|
2005-07-05 |
2014-10-15 |
Purdue Research Foundation |
Pharmaceutical composition for the treatment of osteoarthritis
|
|
US7521195B1
(en)
|
2005-07-21 |
2009-04-21 |
Celera Corporation |
Lung disease targets and uses thereof
|
|
CA2619725C
(en)
|
2005-08-18 |
2016-06-07 |
Ramot At Tel Aviv University Ltd. |
Single chain antibodies against beta-amyloid peptide
|
|
JP4938263B2
(ja)
*
|
2005-08-19 |
2012-05-23 |
独立行政法人農業生物資源研究所 |
一本鎖抗体によるサイトゾルタンパク質の機能阻害法およびその利用
|
|
US7612181B2
(en)
*
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
PT1931710T
(pt)
*
|
2005-08-31 |
2017-03-28 |
Merck Sharp & Dohme |
Anticorpos anti-il-23 manipulados
|
|
ES2543341T3
(es)
|
2005-09-13 |
2015-08-18 |
National Research Council Of Canada |
Métodos y composiciones para modular la actividad de células tumorales
|
|
EP1938104A2
(en)
|
2005-10-17 |
2008-07-02 |
Institute for Systems Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
CN110776566B
(zh)
|
2005-12-20 |
2025-07-15 |
Sbi生物技术有限公司 |
抗ilt7抗体
|
|
JP2009529920A
(ja)
|
2006-03-21 |
2009-08-27 |
ワイス |
Ｒａｇｅの拮抗作用のための方法および組成物
|
|
WO2007143561A1
(en)
|
2006-06-01 |
2007-12-13 |
Mayo Foundation For Medical Education And Research |
Immunity to folate receptors
|
|
ES2444695T3
(es)
|
2006-06-23 |
2014-02-26 |
Alethia Biotherapeutics Inc. |
Polinucleótidos y polipéptidos implicados en el cáncer
|
|
US7910702B2
(en)
|
2006-07-28 |
2011-03-22 |
The Governors Of The University Of Alberta |
Recombinant antibodies to sclerotinia antigens
|
|
WO2008021290A2
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
HUE052220T2
(hu)
|
2006-09-08 |
2021-04-28 |
Abbvie Bahamas Ltd |
Interleukin-13 kötõfehérjék
|
|
EP1900752A1
(en)
*
|
2006-09-15 |
2008-03-19 |
DOMPE' pha.r.ma s.p.a. |
Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma
|
|
NZ601022A
(en)
|
2006-10-12 |
2014-09-26 |
Chugai Pharmaceutical Co Ltd |
Diagnosis and treatment of cancer using anti-ereg antibody
|
|
CA2672581A1
(en)
|
2006-12-14 |
2008-06-19 |
Forerunner Pharma Research Co., Ltd. |
Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same
|
|
CA2832111A1
(en)
|
2006-12-20 |
2008-07-03 |
Mmrglobal, Inc. |
Antibodies and methods for making and using them
|
|
US20080227704A1
(en)
|
2006-12-21 |
2008-09-18 |
Kamens Joanne S |
CXCL13 binding proteins
|
|
US7691980B2
(en)
|
2007-01-09 |
2010-04-06 |
Bio-Rad Laboratories, Inc. |
Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
|
|
EP2129402A2
(en)
|
2007-02-16 |
2009-12-09 |
KTB Tumorforschungsgesellschaft mbH |
Receptor and antigen targeted prodrug
|
|
US20100104626A1
(en)
|
2007-02-16 |
2010-04-29 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
|
CA2678863A1
(en)
|
2007-02-23 |
2008-08-28 |
Schering Corporation |
Engineered anti-il-23p19 antibodies
|
|
US7915368B2
(en)
*
|
2007-05-23 |
2011-03-29 |
Bridgestone Corporation |
Method for making alkoxy-modified silsesquioxanes
|
|
WO2008145136A1
(en)
|
2007-05-30 |
2008-12-04 |
Aarhus Universitet |
Stat3 inactivation by inhibition of the folate receptor pathway
|
|
RU2523909C2
(ru)
|
2007-06-25 |
2014-07-27 |
Эндосайт, Инк. |
Конъюгаты, содержащие гидрофильные спейсеры линкеров
|
|
CN101139613B
(zh)
|
2007-08-01 |
2011-06-08 |
姜荣锡 |
抗肿瘤二元多肽及其应用与制备方法
|
|
ES2538489T3
(es)
*
|
2007-12-12 |
2015-06-22 |
Pincell Srl |
Remedios para pénfigo que contienen anticuerpos contra el ligando Fas
|
|
BRPI0821401A2
(pt)
|
2007-12-21 |
2014-10-14 |
Novartis Ag |
Compostos orgânicos
|
|
AU2009203464A1
(en)
|
2008-01-11 |
2009-07-16 |
Forerunner Pharma Research Co., Ltd. |
Anti-CLDN6 antibody
|
|
EP2275431A3
(en)
|
2008-01-18 |
2011-05-25 |
Bio-Rad Laboratories, Inc. |
Enhanced fractionation of phosphorylated and nonphosphorylated biomolecules by apatite chromotography
|
|
JP5470817B2
(ja)
|
2008-03-10 |
2014-04-16 |
日産自動車株式会社 |
電池用電極およびこれを用いた電池、並びにその製造方法
|
|
WO2009132081A2
(en)
|
2008-04-24 |
2009-10-29 |
The Research Foundation Of State University Of New York |
Monoclonal antibody-based targeting of folate receptors
|
|
KR20210005318A
(ko)
|
2008-04-30 |
2021-01-13 |
이뮤노젠 아이엔씨 |
가교제 및 그 용도
|
|
MX2010011808A
(es)
|
2008-04-30 |
2011-03-04 |
Immunogen Inc |
Conjugados potentes y enlazadores hidrofilicos.
|
|
US8383351B2
(en)
|
2008-06-11 |
2013-02-26 |
Oxford Brookes University |
Antibody to inhibin/ activin β-B subunit
|
|
EP2349274B1
(en)
|
2008-09-17 |
2025-04-09 |
Endocyte, Inc. |
Folate receptor binding conjugates of antifolates
|
|
US20100092470A1
(en)
|
2008-09-22 |
2010-04-15 |
Icb International, Inc. |
Antibodies, analogs and uses thereof
|
|
CN101440130B
(zh)
|
2008-11-21 |
2011-07-27 |
中国人民解放军第四军医大学 |
一种抗人IL-13Rα2单克隆抗体的重链和轻链的可变区
|
|
US20110021555A1
(en)
|
2008-12-19 |
2011-01-27 |
Graceway Pharmaceuticals, Llc |
Lower dosage strength imiquimod formulations and shorter dosing regimens for treating actinic keratoses
|
|
CN102414562B
(zh)
|
2009-03-24 |
2019-05-07 |
生物概念股份有限公司 |
细胞捕获和分析的装置和方法
|
|
EP2462161B1
(en)
|
2009-08-06 |
2017-03-08 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to a beta oligomers and use thereof
|
|
EP2486058A1
(en)
|
2009-10-09 |
2012-08-15 |
Sanofi |
Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same
|
|
WO2011100398A1
(en)
|
2010-02-10 |
2011-08-18 |
Immunogen, Inc. |
Cd20 antibodies and uses thereof
|
|
MY171234A
(en)
|
2010-02-24 |
2019-10-04 |
Immunogen Inc |
Folate receptor 1 antibodies and immunoconjugates and uses thereof
|
|
US8846041B2
(en)
*
|
2010-03-24 |
2014-09-30 |
Genentech, Inc. |
Anti-LRP6 antibodies
|
|
AU2011317088B2
(en)
|
2010-10-20 |
2016-01-21 |
Eisai, Inc. |
Anti-folate receptor alpha antibody glycoforms
|
|
SG10201509145XA
(en)
|
2010-11-05 |
2015-12-30 |
Morphotek Inc |
Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
|
|
JP2014510757A
(ja)
|
2011-03-29 |
2014-05-01 |
イムノゲン インコーポレーティッド |
均質性が改善された複合体を製造する工程
|
|
JP6000329B2
(ja)
|
2011-03-29 |
2016-09-28 |
イムノゲン インコーポレーティッド |
１段階の工程によるマイタンシノイド−抗体複合体の調製
|
|
EP3318273B1
(en)
|
2011-04-01 |
2019-08-21 |
ImmunoGen, Inc. |
Methods for increasing efficacy of folr1 cancer therapy
|
|
US20120282282A1
(en)
|
2011-04-04 |
2012-11-08 |
Immunogen, Inc. |
Methods for Decreasing Ocular Toxicity of Antibody Drug Conjugates
|
|
US9156854B2
(en)
|
2011-04-18 |
2015-10-13 |
Immunogen, Inc. |
Maytansinoid derivatives with sulfoxide linker
|
|
EP2524929A1
(en)
|
2011-05-17 |
2012-11-21 |
Sanofi |
Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of CD19+ B-cell malignancies syptoms
|
|
RS56985B1
(sr)
|
2011-07-15 |
2018-05-31 |
Eisai R&D Man Co Ltd |
Antitela protiv alfa receptora folata i njihove upotrebe
|
|
HUE049693T2
(hu)
|
2012-08-31 |
2020-10-28 |
Immunogen Inc |
Diagnosztikai ASSAY-k és készletek a folát receptor 1 kimutatására
|
|
US20150306242A1
(en)
|
2012-10-04 |
2015-10-29 |
Immunogen, Inc. |
Process for preparing stable antibody maytansinoid conjugates
|
|
JP6136279B2
(ja)
|
2013-01-15 |
2017-05-31 |
株式会社ジェイテクト |
転がり軸受装置
|
|
TWI503850B
(zh)
|
2013-03-22 |
2015-10-11 |
Polytronics Technology Corp |
過電流保護元件
|
|
RU2015149285A
(ru)
|
2013-05-14 |
2017-06-19 |
Иммьюноджен Инк. |
Схемы дозирования иммуноконъюгата anti-folr1
|
|
WO2015026909A2
(en)
|
2013-08-23 |
2015-02-26 |
Nuclea Biotechnologies, Inc. |
Msia-srm assay for biomarker analysis
|
|
LT3038650T
(lt)
|
2013-08-30 |
2021-09-10 |
Immunogen, Inc. |
Antikūnai ir foliatų receptoriaus 1 nustatymo testai
|
|
TWI510996B
(zh)
|
2013-10-03 |
2015-12-01 |
Acer Inc |
控制觸控面板的方法以及使用該方法的可攜式電腦
|
|
DK3653228T3
(da)
|
2013-10-08 |
2024-07-15 |
Immunogen Inc |
Anti-folr1-immunkonjugatdoseringsregimer
|
|
US20150297744A1
(en)
|
2014-03-28 |
2015-10-22 |
Immunogen, Inc. |
Anti-FOLR1 Immunoconjugate Dosing Regimens
|
|
KR20170027805A
(ko)
|
2014-07-01 |
2017-03-10 |
익스프레션 패톨로지, 인크. |
화학요법 표적에 대한 srm 검정
|
|
JP2017526682A
(ja)
|
2014-09-02 |
2017-09-14 |
イミュノジェン， インコーポレイテッド |
抗体薬物複合体組成物の製剤化方法
|
|
KR102700777B1
(ko)
|
2015-09-17 |
2024-08-29 |
이뮤노젠 아이엔씨 |
항-folr1 면역접합체를 포함하는 치료제 조합
|
|
ES2716900T3
(es)
|
2015-11-06 |
2019-06-17 |
Promise Advanced Proteomics |
Un método para cuantificar anticuerpos anti-TNF
|
|
US9816280B1
(en)
|
2016-11-02 |
2017-11-14 |
Matthew Reitnauer |
Portable floor
|
|
MA50098A
(fr)
|
2017-09-05 |
2020-07-15 |
Immunogen Inc |
Procédés de détection du récepteur 1 des folates dans un échantillon provenant d'un patient
|
|
TW202428598A
(zh)
|
2017-09-22 |
2024-07-16 |
美商免疫遺傳股份有限公司 |
使用陽離子交換層析法分離三輕鏈抗體
|
|
TW201934187A
(zh)
|
2018-01-12 |
2019-09-01 |
美商免疫遺傳股份有限公司 |
抗體藥物結合、純化、及調配之方法
|
|
TW202515623A
(zh)
|
2019-04-29 |
2025-04-16 |
美商免疫遺傳股份有限公司 |
雙互補位ＦＲ－α抗體及免疫結合物
|